EP 3383914 A1 20181010 - ANTI-OX40 ANTIBODIES AND METHODS OF USE THEREOF
Title (en)
ANTI-OX40 ANTIBODIES AND METHODS OF USE THEREOF
Title (de)
ANTI-OX40-ANTIKÖRPER UND VERFAHREN ZUR VERWENDUNG DAVON
Title (fr)
ANTICORPS ANTI-OX40 ET LEURS PROCÉDÉS D'UTILISATION
Publication
Application
Priority
- US 201562262371 P 20151202
- US 2016064794 W 20161202
Abstract (en)
[origin: WO2017096281A1] The present disclosure provides antibodies that specifically bind to human OX40 receptor (OX40) and compositions comprising such antibodies. In a specific aspect, the antibodies specifically bind to human OX40 and modulate OX40 activity, e.g., reduce, deactivate, or inhibit OX40 activity. The present disclosure also provides methods for autoimmune or inflammatory diseases or disorders, by administering an antibody that specifically binds to human OX40 and modulates OX40 activity, e.g., reduces, deactivates, or inhibits OX40 activity.
IPC 8 full level
C07K 16/28 (2006.01); A61K 39/395 (2006.01); G01N 33/68 (2006.01)
CPC (source: EP)
C07K 16/2878 (2013.01); C07K 2317/34 (2013.01); C07K 2317/35 (2013.01); C07K 2317/76 (2013.01); G01N 2333/70578 (2013.01)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2017096281 A1 20170608; EP 3383914 A1 20181010; EP 3383914 A4 20191030; MA 43389 A 20210512
DOCDB simple family (application)
US 2016064794 W 20161202; EP 16871651 A 20161202; MA 43389 A 20161202